WEGOVY

उत्पाद अवलोकन

About WEGOVY

WEGOVY is a prescription medication containing the active ingredient semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is used to treat adults with obesity, including those who have had a weight loss of at least 5% or more from their initial body weight with a reduced-calorie diet and increased physical activity alone.

Key Benefits & Uses

• Helps adults with obesity to lose weight and maintain weight loss
• Reduces the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease or multiple cardiovascular risk factors

Active Ingredient & Action

SEMAGLUTIDE works by mimicking the action of a natural hormone in the body called glucagon-like peptide-1 (GLP-1). GLP-1 helps to regulate blood sugar levels and appetite, leading to weight loss and improved glycemic control. SEMAGLUTIDE binds to GLP-1 receptors in the pancreas, stomach, and brain, stimulating the release of insulin and reducing the release of glucagon, a hormone that raises blood sugar levels.

Important Notes

WEGOVY is not a substitute for diet and exercise. It is essential to follow a reduced-calorie diet and increase physical activity to achieve and maintain weight loss. WEGOVY may cause nausea, vomiting, diarrhea, abdominal pain, and injection site reactions. Inform your doctor about any medical conditions, including pancreatitis, thyroid cancer, or a history of depression or suicidal thoughts. Do not use WEGOVY if you are pregnant or breastfeeding.